Study includes multiple variant vaccines.
New arm of NIAID-sponsored mix-and-match trial will look at Novavax protein vaccine.
Lisa Jackson, MD, MPH, explains results support boosting with Moderna, Pfizer, or Johnson & Johnson vaccine.